Four controversies in pediatric asthma care

Asthma management has come a long way in recent years, but many dilemmas remain: When is the right time to make the diagnosis and start anti-inflammatory therapy? What about growth suppression from steroids? Is an inhaler or nebulizer best for acute attacks?

Related Videos
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx -
Related Content
© 2023 MJH Life Sciences

All rights reserved.